BMI View: Mounting pressure from Greece's creditors has prompted the health ministry to announce further measures to reduce pharmaceutical and healthcare expenditure, reaffirming our bleak outlook for the sector going into 2014. There have been some positive developments, such as the announcement that the state budget posted a preliminary primary surplus of EUR2.6bn (US$3.5bn) for H113. However, the state has repeatedly had to bail out the national health insurer, the EOPYY, by extending it funds in order to pay off hospitals, pharmacies and pharmaceutical companies. The principal concern among drugmakers and observers is how Greece will lower its spending next year in 2014 to under EUR2bn (US$2.66bn), when it cannot manage to curtail spending below EUR2.44bn. Headline Expenditure Projection ...